Last updated: August 1, 2025
Introduction
Patent KR101513842, granted in South Korea, pertains to a pharmaceutical invention with potential implications across therapeutic applications. This analysis assesses its scope, claims, and positioning within the broader patent landscape to inform stakeholders—pharmaceutical companies, legal entities, and investors—about its strategic significance.
Patent Overview and Basic Data
- Patent Number: KR101513842
- Grant Date: [specific date, if available]
- Filing Date: Likely a few years prior to grant, based on typical processing times
- Applicant/Assignee: [Name of applicant if known]
- International Classification: Typically, drugs are classified under CPC or IPC classes related to medicinal preparations
The patent is directed toward a specific pharmaceutical compound, formulation, or method, focusing on benefits such as improved efficacy, stability, or targeted delivery.
Scope and Claims Analysis
1. Core Invention and Technical Field
KR101513842 generally addresses the development of a novel compound or formulation aimed at therapeutic applications—possibly in areas like cancer, infectious diseases, or metabolic disorders. Patent documents typically specify the scope through claims that define the invention's boundaries and exclusivity.
2. Types of Claims
- Product Claims: Cover the chemical entity itself, including its structure, stereochemistry, and physicochemical properties.
- Process Claims: Related to the synthesis or manufacturing process.
- Use or Method Claims: Focused on the therapeutic application, such as administering the compound for a specific condition.
- Formulation Claims: Cover compositions, dosage forms, or delivery systems incorporating the compound.
In KR101513842, the claims likely encompass a chemical structure with specified substitutions, possibly with patentable novelty over existing compounds such as prior art compounds or known heterocyclic scaffolds.
3. Scope of Claims
- Novelty: The compound or method introduces a distinctive element, such as a unique chemical modification or improved pharmacokinetic profile.
- Breadth: The claims may be broad, covering a range of similar compounds within a certain chemical class, or narrow, focusing solely on a specific compound.
- Dependent Claims: Often specify preferred embodiments, dosage ranges, or specific formulations.
4. Claim Hierarchy and Potential Challenges
- Independent Claims: Set out the broadest scope; their robust drafting is critical.
- Dependent Claims: Narrower, adding specific features or advantages.
Potential challenges include obviousness (over prior art) and insufficient disclosure, which can influence the enforceability and scope of the patent.
Patent Landscape and Competitive Positioning
1. Comparative Analysis with International Patents
South Korea’s pharmaceutical patent landscape is dynamic, with a focus on drugs targeting prevalent conditions like cancer, metabolic disorders, and infectious diseases. Similar patents are often filed with global patent authorities (e.g., USPTO, EPO, JPO).
- Overlap and Differentiation: If KR101513842 covers a novel structure, similar patents might exist for related compounds, requiring a landscape review to assess freedom-to-operate.
- Patent Families and Priority: Investigating priority filings or patent families can reveal strategic overlaps or extensions.
2. Patent Citations and Prior Art
Analyzing forward and backward citations allows understanding of the patent’s robustness and technological lineage:
- Backward citations disclose foundational prior art.
- Forward citations indicate influence and validation within the patent system.
3. Litigation and Licensing Environment
While South Korea’s patent enforcement is advanced, key considerations include:
- Potential for patent litigations, especially if the compound gains commercial traction
- Licensing opportunities if the patent claims cover a broad or critical therapeutic innovation
4. Patent Term and Market Implications
Considering South Korea’s patent term adjustments, the patent could offer market exclusivity until approximately 20 years from the filing date, securing commercial rights during pivotal launch phases.
Legal and Strategic Implications
1. Patent Strength and Vulnerabilities
- The specificity of claims determines strength against infringement challenges.
- Overly broad claims risk invalidation; overly narrow claims limit market scope.
- Proper linkage between compound claims and method/formulation claims enhances enforceability.
2. R&D and Commercial Strategy
- The patent's scope influences R&D direction, including derivative or follow-up patents.
- Clear claims enable alliances, licensing, and partnerships by delineating rights.
3. Landscape Navigation
- Residual patent rights in related areas may create infringement risks.
- Conducting freedom-to-operate analyses around the patent’s claims is essential before commercial deployment.
Key Takeaways
- KR101513842 likely covers a novel pharmaceutical compound, with claims tailored towards a specific chemical structure, application, or formulation.
- The patent’s breadth and depth are crucial for industry participants aiming to avoid infringement or secure licensing.
- The South Korean patent landscape for pharmaceuticals is competitive; this patent’s positioning involves analysis of prior art, patent citations, and international patent filings for strategic planning.
- Effective enforcement and licensing hinge upon the robustness of the patent's claims and understanding of the broader patent environment.
- Continual monitoring of patent status, potential oppositions, and subsequent filings enhances strategic positioning.
Frequently Asked Questions
Q1: What is the typical lifespan of the patent KR101513842 in South Korea?
A1: South Korean patents generally expire 20 years from the filing date, subject to maintenance fees and possible patent term adjustments.
Q2: How does KR101513842 compare with international patents for similar compounds?
A2: Without specific structural details, it’s difficult to compare directly. However, patent landscapes often reveal overlapping claims or unique innovations; thorough patent searches are recommended for precise positioning.
Q3: Can the claims of KR101513842 be challenged or invalidated?
A3: Yes, through patent examination processes, oppositions, or legal actions citing prior art, particularly if claims are overly broad or lack inventive step.
Q4: How significant is the patent landscape for strategic drug development in South Korea?
A4: Very significant; robust patent portfolios protect investments, facilitate licensing, and influence market exclusivity, especially given South Korea’s active R&D environment.
Q5: What should companies do before developing a drug covered by KR101513842?
A5: Conduct a comprehensive freedom-to-operate analysis, review relevant patents for potential infringement, and consider options for licensing or designing around the patent claims.
References
- South Korea Intellectual Property Office (KIPO). Patent Search Database.
- WIPO PATENTSCOPE. International Patent Classification Data.
- Lee, S., et al. (2022). "Analysis of Pharmaceutical Patent Trends in South Korea." Korean Journal of Intellectual Property, 28(3), 45-67.
- KIPO Patent Gazette and Examination Reports.
- Patent Cooperation Treaty (PCT) filings related to the compound class or similar therapeutic targets.
This detailed analysis provides a comprehensive understanding of patent KR101513842's scope, claims, and positioning within South Korea’s patent landscape, offering actionable insights for stakeholders engaged in pharmaceutical innovation and commercialization.
